🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Glenview to meet top CVS execs, propose operational improvements, WSJ reports

Published 09/29/2024, 07:26 PM
Updated 09/29/2024, 08:32 PM
© Reuters. FILE PHOTO: A general view shows a sign of CVS Health Retail Pharmacy Customer Care Center, at CVS headquarters of CVS Health Corp in Woonsocket, Rhode Island, U.S. October 30, 2023. REUTERS/Faith Ninivaggi/File Photo
CVS
-

(Reuters) - Healthcare-focused Glenview Capital Management will meet top executives at struggling healthcare company CVS Health (NYSE:CVS) on Monday to propose ways it can improve operations, The Wall Street Journal reported on Sunday.

The hedge fund's founder, Larry Robbins, has built a large position in CVS, which amounts to about $700 million of his $2.5 billion hedge fund, the report said, citing a person familiar with the matter.

CVS said it "maintains a regular dialogue with the investment community as part of our robust shareholder and analyst engagement program," and said it can't comment on engagement with specific firms or individuals.

Glenview did not immediately respond to a Reuters' request for comment.

Speculation has mounted among fund managers that an activist investor may swoop in to push CVS to make changes that would boost its share price.

Investment firm Sachem Head Capital Management built a new 0.2% stake in the company during the second quarter, according to a regulatory filing in August.

Earlier in August, CVS cut its annual profit forecast to $6.40 to $6.65 per share from its prior view of at least $7.00, marking at least the fourth time CVS lowered its outlook for the year.

© Reuters. FILE PHOTO: A general view shows a sign of CVS Health Retail Pharmacy Customer Care Center, at CVS headquarters of CVS Health Corp in Woonsocket, Rhode Island, U.S. October 30, 2023. REUTERS/Faith Ninivaggi/File Photo

It also announced a multi-year plan to save $2 billion in costs through measures such as streamlining operations and using artificial intelligence and automation across its business.

(This story has been corrected to say outlook has been revised three times, not four, in paragraph 7)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.